Thomas G. Cotter, Jennifer Wang, Thoetchai Peeraphatdit, Burhaneddin Sandıkçı, Fares Ayoub, Gene Kim, Helen Te, Valluvan Jeevanandam, Diego Sabato, Michael Charlton – 19 June 2020
Daniela Kniepeiss, Philipp Stiegler, Emina Talakic, Peter Schemmer – 19 June 2020
Bei Gao, Yi Duan, Sonja Lang, Dinesh Barupal, Tsung‐Chin Wu, Luis Valdiviez, Bryan Roberts, Ying Yng Choy, Tong Shen, Gregory Byram, Ying Zhang, Sili Fan, Benjamin Wancewicz, Yan Shao, Kevin Vervier, Yanhan Wang, Rongrong Zhou, Lu Jiang, Shilpa Nath, Rohit Loomba, Juan G. Abraldes, Ramon Bataller, Xin M. Tu, Peter Stärkel, Trevor D. Lawley, Oliver Fiehn, Bernd Schnabl – 19 June 2020 – Alcohol‐related liver disease is a major public health burden, and the gut microbiota is an important contributor to disease pathogenesis.
James B. Hendele, James D. Perkins, Lena Sibulesky – 18 June 2020
Roman Kloeckner, Peter Robert Galle, Jordi Bruix – 18 June 2020
Yun Seok Kim, Hyeon Joo Nam, Chang Yeob Han, Min Sung Joo, Kiseok Jang, Dae Won Jun, Sang Geon Kim – 17 June 2020
Mark W. Russo, Oren K. Fix, Ayman A. Koteish, Katie Duggan, Marcia Ditmyer, Michael Fuchs, Raymond T. Chung, Gautham Reddy – 17 June 2020
Xiude Fan, Rebecca L. McCullough, Emily Huang, Annette Bellar, Adam Kim, Kyle L. Poulsen, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Daniel M. Rotroff, Laura E. Nagy – 17 June 2020
David M. Chascsa, Elise M. N. Ferré, Yannis Hadjiyannis, Hawwa Alao, Mukil Natarajan, Mariam Quinones, David E. Kleiner, Thomas L. Simcox, Ehsan Chitsaz, Stacey R. Rose, Asa Hallgren, Olle Kampe, Jamie Marko, Rabab O. Ali, Sungyoung Auh, Christopher Koh, Yasmine Belkaid, Michail S. Lionakis, Theo Heller – 17 June 2020
Zobair M. Younossi, Mary E. Rinella, Arun J. Sanyal, Stephen A. Harrison, Elizabeth M. Brunt, Zachary Goodman, David E. Cohen, Rohit Loomba – 16 June 2020 – Despite the substantial gains in our understanding of NAFLD/NASH over the past 2 decades, there has been some dissatisfaction with the terminology “non‐alcoholic” which overemphasizes “alcohol” and underemphasizes the root cause of this liver disease, namely, the predisposing metabolic risk factors. As a potential remedy, a name change from NAFLD to metabolic associated fatty liver disease (MAFLD) has been proposed.